Neurolytic Healthcare, Inc. (Mable) is revolutionizing neurological care by integrating genetic and biomarker data into personalized treatment plans. Through its genomics-based telehealth platform, the company provides DNA testing, online consultations, and precision medicine options for patients. Mable's services are designed for individuals with recurrent or chronic migraines seeking convenient and data-driven therapeutic solutions.
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos